43. Breast. 2018 Aug;40:10-15. doi: 10.1016/j.breast.2018.03.014. Epub 2018 Apr 14.Propensity score to evaluate prognosis in pregnancy-associated breast cancer:Analysis from a French cancer network.Boudy AS(1), Naoura I(2), Selleret L(2), Zilberman S(2), Gligorov J(3), RichardS(3), Thomassin-Naggara I(4), Chabbert-Buffet N(5), Ballester M(5), BendifallahS(2), Darai E(5).Author information: (1)Department of Gynaecology and Obstetrics, Tenon University Hospital,Assistance Publique des Hôpitaux de Paris (AP-HP), Faculté de Médecine SorbonneUniversité, Institut Universitaire de Cancérologie (IUC), France; Centre CALG(Cancer Associé à La Grossesse), France. Electronic address:annesophie.boudy@aphp.fr.(2)Department of Gynaecology and Obstetrics, Tenon University Hospital,Assistance Publique des Hôpitaux de Paris (AP-HP), Faculté de Médecine SorbonneUniversité, Institut Universitaire de Cancérologie (IUC), France; Centre CALG(Cancer Associé à La Grossesse), France.(3)Centre CALG (Cancer Associé à La Grossesse), France; Department of Oncology,Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP),Faculté de Médecine Sorbonne Université, Institut Universitaire de Cancérologie(IUC), France.(4)Department of Radiology, Tenon University Hospital, Assistance Publique desHôpitaux de Paris (AP-HP), Faculté de Médecine Sorbonne Université, InstitutUniversitaire de Cancérologie (IUC), France.(5)Department of Gynaecology and Obstetrics, Tenon University Hospital,Assistance Publique des Hôpitaux de Paris (AP-HP), Faculté de Médecine SorbonneUniversité, Institut Universitaire de Cancérologie (IUC), France; Centre CALG(Cancer Associé à La Grossesse), France; UMRS-938 4. Faculté de Médecine SorbonneUniversité, France.PURPOSE: To compare the prognosis of pregnancy associated breast cancer occurringduring pregnancy (BCP) to non-pregnancy associated breast cancers (non-BCP) inyoung women managed at a national expert center.METHODS: Retrospective cohort study of a prospective database using propensityscore matching (PSM) analysis with known prognostic factors.RESULTS: We analyzed data of 49 patients with BCP and 104 with non-BCP diagnosed between 2002 and 2017 at Tenon University Hospital (Paris, France). The BCPtumors were often locally advanced (lymph node metastases in 59%), of high grade (55%) and highly proliferative (67% with Ki67 ≥ 20%). After PSM, breastcancer-free survival (p = 0.45) and breast cancer specific survival (p = 0.81)were similar in the two groups. The recurrence rate was 12% vs 18% (p = 0.45) andthe death rate was 6% vs 8% (p = 0.74) for the BCP and non-BCP groups,respectively. No difference in recurrence type was observed between the groups(p = 0.60).CONCLUSIONS: After PSM for known prognostic factors, the prognosis of BCPpatients did not differ from that of young patients with non-BCP.Copyright © 2018 Elsevier Ltd. All rights reserved.DOI: 10.1016/j.breast.2018.03.014 PMID: 29665447 